| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.2 | 6e-09 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.16 | 9e-06 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.0007 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.16 | 0.002 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.099 | 0.004 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.099 | 0.005 |